# "SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

> **NCT00201994** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 243 (actual)

## Conditions studied

- Hyponatremia
- Water Intoxication
- Inappropriate ADH Syndrome
- Water-electrolyte Imbalance

## Interventions

- **DRUG:** Tolvaptan

## Key facts

- **NCT ID:** NCT00201994
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2012-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00201994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00201994, ""SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00201994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*